New international exercise guidelines for cancer survivors
The updated recommendations outline specific ‘exercise prescriptions’ to address common side effects associated with cancer diagnoses and treatment.
Study finds lack of racial diversity in cancer drug clinical trials
New research led by Jonathan Loree found a lack of racial and ethnic diversity in clinical trials for cancer drugs.
High insulin production may contribute to pancreatic cancer
Led by PhD student Anni Zhang, UBC study is first to demonstrate a causal link between high insulin levels and pancreatic cancer.
New treatment knocks out cancer with a one-two punch
Developed by Shoukat Dedhar, new cancer treatment has potential to be a heavy hitter when combined with existing therapies.
Steroids can reduce lung cancer risk in COPD patients
New UBC study co-authored by Don Sin evaluated 10 years’ worth of medical and pharmacy data.
Award supports research into broad-spectrum childhood cancer treatments
Mads Daugaard is given carte blanche to discover solid tumour treatments for children.
A new way of diagnosing and treating disease — without cutting skin
UBC researchers develop new laser microscope that could be ‘revolutionary’ for treatment of diseases such as skin cancer.
Putting Canada at the forefront of precision medicine
Sriram Subramaniam joins UBC as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.
Dr. Connie Eaves awarded the 2019 Canada Gairdner Wightman Award
Dr. Eaves recognized as one of the most creative and accomplished biomedical scientists advancing solutions to problems facing humanity around the world.
Translating research to treat prostate cancer
Dr. Martin Gleave leads a team of cancer researchers at the Vancouver Prostate Centre.